Cordlife Group Limited · SGX:P8A
Cordlife — 1QFY2019 Earnings Presentation
18 slides from Cordlife's earnings presentation, 2019
Slide 1: 1QFY2019 Results Presentation
1QFY2019 Results Presentation
Slide 2: Disclaimer
Disclaimer This presentation does not constitute, or form any part of any offer for sale or subscription of, or solicitation of any offer to buy or subscribe for, any securities in Cordlife Group Limited (“Cordlife”) in Singapore or any other jurisdiction nor shall it or any part of it form the basi
Slide 3: Content
Content 1 Overview 2 Corporate Developments 3 Financial Highlights 4 Growth Strategies & Outlook 3
Slide 4: Overview
Overview 4
Slide 5: Business Overview – Operating Segments
Business Overview – Operating Segments Banking Diagnostics Cord Blood Banking Non-invasive Newborn Metabolic Screening Collection at birth, processing, A non-invasive, early detection test specially testing, cryopreservation and storage designed to screen inherited metabolic of stem cells from t
Slide 6: Business Overview – Market Presence
Our Reach Business Overview – Market Presence Banking Services Cordlife’s Headquarters Cordlife’s Subsidiaries Cordlife’s Associate Hong Kong Cordlife’s Marketing Agents India Diagnostics Services Myanmar Thailand Philippines Vietnam Malaysia Singapore Hong Kong India Philippines Indonesia Malaysia
Slide 7: Corporate Developments
Corporate | Developments cordlife ee
Slide 8: Corporate Developments
Corporate Developments Collaboration with Sandor on diagnostics in India - Founded by Mr. Rajeev Sindhi, Sandor is a pan India exclusive marketer & distributor of specialized drugs/devices to the hospital segment in India & Bangladesh. - Co-launched pre natal and post natal diagnostics tests in 35-4
Slide 9: Financial Highlights
Financial Highlights | cordlife ee
Slide 10: 1Q2019 Results Summary
1Q2019 Results Summary REVENUE GROSS PROFIT GP MARGIN S$16.6 million S$11.2 million 67.3% (4.3%) y-o-y (3%) y-o-y +90 bps y-o-y NET PROFIT NET PROFIT MARGIN NET CASH S$0.9 million 5.6% S$43.5 million 47.7% y-o-y +190 bps y-o-y 10
Slide 11: Financials - Revenue
Financials - Revenue S$ mil 120 105.0 100 92.9 80 60 57.6 59.6 49.1 40 20 17.4 16.6 0 FY2014* FY2015* FY2016* 18M2017* 18M2018* 1Q2018# 1Q2019# (restated) Singapore India Hong Kong Malaysia Philippines Others * Prepared in accordance with FRS18 – Revenue. 11 # Prepared in accordance with SFRS(I) 15
Slide 12: Financials – Gross Profit
Financials – Gross Profit S$ mil % 69.40 % 71.1 % 90.0 66.30 % 65.40 % 67.70 % 66.40 % 70.0 67.30 % 80.0 71.1 70.0 55.0 60.8 60.0 50.0 39.5 40.0 40.0 40.0 34.9 30.0 25.0 20.0 11.5 11.2 10.0 - 10.0 FY2014* FY2015* FY2016* 18M2017* 18M2018* 1Q2018# 1Q2019# (restated) Gross Profit Gross Profit Margin *
Slide 13: Financials – Net Profit
Financials – Net Profit S$ mil 10.0 15.5 % 8.7 % 15 9.0 3.7 % 3.0 % 5.0 % 3.7 % 8.0 7.6 5.6 % 0 7.0 6.0 5.2 -15 5.0 5.0 4.0 -30 3.0 2.8 2.2 2.0 -45 0.6 0.9 1.0 - -60 FY2014^* FY2015^* FY2016^* 18M2017^* 18M2018^* 1Q2018# 1Q2019# (restated) Net Profit Net Profit Margin ^ Excludes one-off items * Prep
Slide 14: Financials – Balance Sheet
Financials – Balance Sheet As at 31 Dec 2018 S$’ mil As at 31 Mar 2019 (restated) Net Assets 119.1 117.9 Borrowings 4.5 4.6 Gearing (%) 3.8 3.8 Cash & Cash Equivalents, Fixed 48.0 43.3 Deposits and Short-term Investments Net Asset Value Per Share (SG cents) 47.00 46.53 14
Slide 15: Financials – Cash Flow
Financials – Cash Flow As at 31 Dec 2018 S$’ mil As at 31 Mar 2019 (restated) Net cash generated from operating activities 2.7 3.3 Net cash used in investing activities (1.5) (10.1) Net cash used in financing activities (0.1) (2.8) Cash & cash equivalents at end of the 12.3 12.4 financial period 15
Slide 16: Growth Strategies
Growth Strategies | cordlife ee
Slide 17: Growth Strategies
Growth Strategies • To increase penetration rate/market share • To increase market depth Organic Growth • To facilitate development of stem cell ecosystem • To create new engines of growth • Synergistic with current business M&A • Earnings accretive • Targeting Asia 17
Slide 18: Thank you
Thank you 18